Rosatom is continuing to sterilise medical products to combat the COVID-19 coronavirus, having sterilised over 20,8 mln medical masks as of the morning of May 15 (1,182,860 over the course of May 14  alone), as well as 292,500  portable lab kits to test for COVID-19.

Sterilisation is being carried out by Sterion JSC (a JSC Rusatom Healthcare subsidiary), which has concluded a contract with Delrus to sterilise more than 58 million masks. The company transitioned from a two-shift to a three-shift (i.e. round-the-clock) work schedule to up its capacity and process up to 10 million masks per week.

As part of its contract with HEM Ltd., Sterion JSC is also sterilising portable test kits.  JSC Sterion sterilises medical supplies using specialised equipment manufactured by Rosatom’s other enterprises, its main tool being the UEL 10 kW linear electron accelerator. Sterilisation up to a sterility assurance level (SAL) of 10−6 is achieved by means of targeting the medical kits, pre-loaded onto a conveyor belt, with a beam of accelerated electrons. This method allows for the safe sterilisation of medical supplies without the need to unpack them from the shipping containers provided by manufacturers. After being processed with a stream of accelerated electrons, the supplies immediately become usable and do not require degassing (as would have been the case with several other sterilisation methods) or any other additional actions before actual use. One box containing 980 masks can be processed in 37 seconds.

JSC Karpov NIFHI and JSC NIITFA  (JSC Rusatom Healthcare subsidiaries) are also continuing to sterilise medical supplies.